Provided By GlobeNewswire
Last update: Jun 26, 2025
SASKATOON, Saskatchewan, June 26, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that, pursuant to a share purchase agreement dated June 24, 2025, it has agreed to acquire from arm’s length vendors (the “Vendors”) a 100% interest in a PharmaChoice Canada bannered pharmacy business located in Western Canada (the “Acquisition”). The purchase price for the Acquisition is $2,400,000, subject to customary adjustments (the “Purchase Price”), which will be paid using cash on hand. The Purchase Price is subject to a net asset value adjustment as of the closing date. The Acquisition is expected to close on or about July 31, 2025, subject to satisfaction of customary closing conditions. No finder’s fee is payable in respect of the Acquisition.
Read more at globenewswire.com